Clinical Trial Update: Study of Biodistribution, Metabolism, Excretion and Brain Uptake of 11C-HY-2-15 [EARLY_Phase 1]

View source ↗

Summary

This EARLY Phase 1 study at the University of Pennsylvania is evaluating the biodistribution, metabolism, excretion, and brain uptake of the radiotracer 11C-HY-…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Tauopathies

Drugs mentioned

• 11C-HY-2-15

Snippet

Sponsor: University of Pennsylvania | Conditions: Tauopathies | EARLY_Phase 1 | Status: RECRUITING